[ORGANIZATION]
Mesoblast Ltd.
Featured in 1 tracked story · first seen
Situations
US biotech Q2 earnings reports
2 clusters · 12 sources · last updated
Latest: Amgen posts 9% Q2 sales growth and earnings beat as biotech peers report results
In late July 2026 Biogen posted a modest 3% year‑over‑year revenue rise to $2.7 billion, driven by its multiple‑sclerosis drugs and newer products such as Skyclarys and Leqembi. A week later Amgen reported stronger Q2 pe